angiotensin ii, des-phe(8)- has been researched along with bradykinin in 57 studies
Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
---|---|---|---|---|---|
1,533 | 21 | 995 | 14,195 | 355 | 1,520 |
Protein | Taxonomy | angiotensin ii, des-phe(8)- (IC50) | bradykinin (IC50) |
---|---|---|---|
B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 17 (29.82) | 18.2507 |
2000's | 26 (45.61) | 29.6817 |
2010's | 11 (19.30) | 24.3611 |
2020's | 3 (5.26) | 2.80 |
Authors | Studies |
---|---|
Khosla, MC; Lima, CV; Paula, RD; Santos, RA | 1 |
Busse, R; Hecker, M | 1 |
Bara, AT; Busse, R; Hecker, M; Pörsti, I | 1 |
Brosnihan, KB; Chappell, MC; Ferrario, CM; Li, P | 1 |
Higson, JT; Tallant, EA | 1 |
Abbas, A; Carbini, LA; Gorelik, G; Scicli, AG | 1 |
Khosla, MC; Lima, CV; Paula, RD; Resende, FL; Santos, RA | 1 |
Chappell, MC; Ferrario, CM; Iyer, SN | 1 |
Chappell, MC; Ferrario, CM; Pirro, NT; Sykes, A | 1 |
Deddish, PA; Erdös, EG; Jackman, HL; Marcic, B; Skidgel, RA; Wang, HZ | 1 |
Carbini, LA; Gorelik, G; Scicli, AG | 1 |
Brosnihan, KB; Ferrario, CM; Li, P; Tallant, EA | 1 |
Brosnihan, KB | 1 |
Bomtempo, CA; Campagnole-Santos, MJ; Santos, GF; Santos, RA | 1 |
Britto, RR; Campagnole-Santos, MJ; Khosla, MC; Lima, CV; Paula, RD; Santos, RA | 1 |
Davie, AP; McMurray, JJ | 1 |
De Carvalho, MH; Fortes, ZB; Kosla, MC; Oliveira, MA; Santos, RA | 1 |
Almeida, AP; Campagnole-Santos, MJ; Frábregas, BC; Madureira, MM; Santos, RA; Santos, RJ | 1 |
Fernández, BE; Gironacci, MM; Peña, C; Rodriguez-Fermepín, M; Vatta, M | 1 |
Catelli De Carvalho, MH; Fernandes, L; Fortes, ZB; Nigro, D; Santos, RA; Tostes, RC | 1 |
Brown, NJ; Gainer, JV; Murphey, LJ; Vaughan, DE; Wilsdorf, T | 1 |
Danser, AH; de Vries, R; Saxena, PR; Tom, B | 1 |
Almeida, AP; Ferreira, AJ; Santos, RA | 1 |
Brosnihan, KB; Ishii, M; Masumori-Maemoto, S; Ueda, S; Umemura, S; Wada, A | 1 |
Bradley, WE; Brosnihan, KB; Dell'Italia, LJ; Farrell, DM; Ferrario, CM; Jaffa, AA; Wei, CC | 1 |
Carvalho, MH; Fortes, ZB; Nigro, D; Oliveira, MA; Passaglia, Rde C | 1 |
Caruso-Neves, C; Fernandes, MS; Leão-Ferreira, LR; Lopes, AG; Luz, FF; Provenzano, K; Santos, FM | 1 |
Danser, AH; Dendorfer, A; Tom, B | 1 |
Caruso-Neves, C; Fernandes, MS; Leão-Ferreira, LR; Lopes, AG; Quintana-Gomes, E; Santos, DP; Soares, AC | 1 |
Correia, ML; de Carvalho, LC; Emiliano, AF; Mendes-Ribeiro, AC; Resende, AC; Soares de Moura, R; Tano, T | 1 |
Gironacci, MM; Gorzalczany, S; Peña, C; Taira, C; Yujnovsky, I | 1 |
Campagnole-Santos, MJ; de Carvalho, MH; Fernandes, L; Maia, LG; Ramos, MC; Souza dos Santos, RA | 1 |
Nishio, I; Tsuda, K | 1 |
Casarini, DE; de Carvalho, MH; Fernandes, L; Fortes, ZB; Nigro, D; Santos, RA; Tostes, RC | 1 |
Chen, Z; Deddish, PA; Erdös, EG; Tan, F | 1 |
Baber, SR; Fokin, A; Greco, AJ; Kadowitz, PJ; Master, RG | 1 |
de Carvalho, MH; de Cássia Tostes Passaglia, R; dos Santos, R; Fortes, ZB; Nigro, D; Oliveira, MA; Rastelli, VM | 1 |
Chlopicki, S; Fedorowicz, A; Kozlovski, VI; Lomnicka, M | 1 |
Campagnole-Santos, MJ; Carvalho, MB; da Mata Machado, LT; de Paula, RD; Duarte, FV; Faria-Silva, R; Fauler, B; Santos, RA | 1 |
Azcutia, V; Gembardt, F; Heringer-Walther, S; Peiró, C; Rodríguez-Mañas, L; Sánchez-Ferrer, CF; Schultheiss, HP; Vallejo, S; Walther, T | 1 |
Luft, FC | 1 |
Lu, J; Shi, J; Zhang, Y | 1 |
Grobe, JL; Katovich, MJ; Raizada, MK | 1 |
Arranz, C; Costa, MA; Gironacci, MM; Gomez, KA; Lopez Verrilli, MA; Nakagawa, P; Peña, C | 1 |
Ehlers, PI; Korpela, R; Nurmi, L; Turpeinen, AM; Vapaatalo, H | 1 |
Arnold, AC; Chappell, MC; Diz, DI; Isa, K; Westwood, BM | 1 |
Coffman, TM; Danser, AH; Gembardt, F; Schultheiss, HP; van Veghel, R; Walther, T | 1 |
Azcutia, V; Gembardt, F; Hermenegildo, C; Novella, S; Palacios, E; Peiró, C; Rodríguez-Mañas, L; Sánchez-Ferrer, CF; Vallejo, S; Walther, T | 1 |
Khang, G; Raffai, G; Vanhoutte, PM | 1 |
Chappell, MC; Diz, DI; Marshall, AC; Pirro, NT; Rose, JC | 1 |
Cheng, CP; Cheng, HJ; Ferrario, CM; Li, T; Zhou, P | 1 |
Aragão, DS; Arita, DY; Bertoncello, N; Casarini, DE; Cunha, TS; Dantas, PS; Mattar-Rosa, R; Moreira, RP; Santos, R; Watanabe, IK; Yokota, R | 1 |
Korpela, R; Siltari, A; Vapaatalo, H | 1 |
Lombard, JH; Raffai, G | 1 |
Bernstein, EA; Bernstein, KE; Cao, D; Giani, JF; Gonzalez-Villalobos, RA; Khan, Z; Okwan-Duodu, D; Shen, JZY; Veiras, LC | 1 |
Kouketsu, T; Otsubo, Y; Shimada, H; Sugawara, A; Suzuki, S; Yokoyama, A | 1 |
Galal, SM; Hasan, HF; Mohmed, HK | 1 |
6 review(s) available for angiotensin ii, des-phe(8)- and bradykinin
Article | Year |
---|---|
[Endothelial mechanisms in vasomotor effects of ACE inhibitors].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Culture Techniques; Endothelium, Vascular; Hemodynamics; Humans; Nitric Oxide; Peptide Fragments; Receptors, Bradykinin; Vasomotor System | 1994 |
Angiotensin-(1-7): a novel vasodilator of the coronary circulation.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Coronary Circulation; Dogs; Peptide Fragments; Vasodilator Agents | 1998 |
Effect of the angiotensin-(1-7) peptide on nitric oxide release.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Dose-Response Relationship, Drug; Drug Interactions; Humans; Muscle, Smooth, Vascular; Nitric Oxide; Peptide Fragments; Vasoconstrictor Agents; Vasodilation | 1998 |
Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Endothelium, Vascular; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin | 2003 |
Angiotensin-(1-7) as an antihypertensive, antifibrotic target.
Topics: Angiotensin I; Antihypertensive Agents; Blood Pressure; Bradykinin; Cardiotonic Agents; Fibrinolytic Agents; Humans; Hypertension; Nitric Oxide; Peptide Fragments; Receptors, Cell Surface; Renin-Angiotensin System; Signal Transduction | 2008 |
Novel roles of the renal angiotensin-converting enzyme.
Topics: Acute Kidney Injury; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Bradykinin; Diabetic Nephropathies; Gene Expression Regulation; Humans; Hypertension; Kidney; Mice; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction; Water-Electrolyte Balance | 2021 |
2 trial(s) available for angiotensin ii, des-phe(8)- and bradykinin
Article | Year |
---|---|
Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Cardiac Output, Low; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Rate; Humans; Male; Peptide Fragments | 1999 |
Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man.
Topics: Adult; Angiotensin I; Angiotensin II; Bradykinin; Cross-Over Studies; Double-Blind Method; Drug Synergism; Enzyme Inhibitors; Humans; Male; omega-N-Methylarginine; Peptide Fragments; Reference Values; Vasoconstrictor Agents; Vasodilation | 2001 |
49 other study(ies) available for angiotensin ii, des-phe(8)- and bradykinin
Article | Year |
---|---|
Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blood Pressure; Bradykinin; Dose-Response Relationship, Drug; Drug Synergism; Enalaprilat; Indomethacin; Male; Peptide Fragments; Prostaglandins; Rats; Rats, Wistar; Renin-Angiotensin System; Vasoconstrictor Agents | 1995 |
Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor.
Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Animals; Arginine; Bradykinin; Coronary Vessels; Endothelium, Vascular; In Vitro Techniques; Isoquinolines; Molecular Sequence Data; Muscle Relaxation; Nitric Oxide; Nitroarginine; Peptide Fragments; Receptors, Angiotensin; Swine; Tetrahydroisoquinolines; Vasodilator Agents | 1994 |
Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Indomethacin; Male; Peptide Fragments; Vasodilation | 1997 |
Angiotensin II activates distinct signal transduction pathways in astrocytes isolated from neonatal rat brain.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Astrocytes; Biphenyl Compounds; Bradykinin; Brain; Cells, Cultured; Cerebellum; Cerebral Cortex; Epoprostenol; Humans; Hypothalamus; Imidazoles; Losartan; Medulla Oblongata; Peptide Fragments; Phosphatidylinositol Diacylglycerol-Lyase; Pyridines; Rats; Rats, Sprague-Dawley; Signal Transduction; Tetrazoles; Type C Phospholipases | 1997 |
Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Drug Synergism; Hypotension; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley | 1997 |
Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Bradykinin; Drug Synergism; Hypertension; Male; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Wistar | 1997 |
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dipeptides; Heart Rate; Hypertension; Kinetics; Lisinopril; Losartan; Male; Neprilysin; Organophosphonates; Peptide Fragments; Peptides, Cyclic; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1998 |
Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cell Membrane; Dogs; Humans; Kinetics; Lisinopril; Lung; Models, Chemical; Peptide Fragments; Peptidyl-Dipeptidase A | 1998 |
N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arachidonic Acid; Bradykinin; Chlorides; CHO Cells; Cricetinae; Enzyme Repression; Humans; Hydrolysis; Peptide Fragments; Peptidyl-Dipeptidase A; Substrate Specificity; Transfection | 1998 |
Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Coronary Vessels; Imidazoles; In Vitro Techniques; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Receptor, Bradykinin B2; Receptors, Bradykinin; Substance P; Swine; Vasodilation | 1998 |
Interaction of bradykinin and angiotensin-(1-7) in the central modulation of the baroreflex control of the heart rate.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Animals; Baroreflex; Bradykinin; Bradykinin Receptor Antagonists; Drug Synergism; Heart Rate; Injections, Intraventricular; Male; Peptide Fragments; Rats; Rats, Wistar | 1998 |
Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Drug Synergism; Infusions, Intravenous; Injections, Intravenous; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Wakefulness | 1999 |
Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Bradykinin; Bradykinin Receptor Antagonists; Drug Synergism; Enalaprilat; Mesenteric Arteries; Nitric Oxide; Peptide Fragments; Prostaglandins; Rats; Rats, Wistar; Receptor, Bradykinin B2; Vasodilation; Vasodilator Agents | 1999 |
Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart.
Topics: Analysis of Variance; Angiotensin I; Animals; Bradykinin; Cardiovascular Agents; Coronary Vessels; Drug Synergism; Enzyme Inhibitors; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Rats; Rats, Wistar; Vasodilator Agents | 2000 |
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Bradykinin; Cyclooxygenase Inhibitors; Hypothalamus; Indomethacin; Male; Neurons; Nitric Oxide; Norepinephrine; Peptide Fragments; Potassium Chloride; Prostaglandins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2000 |
Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterioles; Bradykinin; Drug Synergism; Hypertension; Male; Mesenteric Arteries; Peptide Fragments; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasodilation | 2001 |
Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm.
Topics: Adult; Angiotensin I; Antihypertensive Agents; Bradykinin; Drug Synergism; Female; Forearm; Humans; Male; Peptide Fragments; Regional Blood Flow; Statistics, Nonparametric; Tissue Plasminogen Activator; Vasodilation; Vasodilator Agents | 2001 |
Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Coronary Vessels; Drug Synergism; Female; Humans; In Vitro Techniques; Isoquinolines; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Receptor, Bradykinin B2; Receptors, Bradykinin; Swine; Tetrahydroisoquinolines; Vasodilation | 2001 |
Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradykinin; Heart Ventricles; In Vitro Techniques; Indomethacin; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Rats; Rats, Wistar | 2001 |
Angiotensin peptides modulate bradykinin levels in the interstitium of the dog heart in vivo.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Bradykinin; Dogs; Heart; Hemodynamics; Imidazoles; Microdialysis; Myocardium; Peptide Fragments; Peptides; Pyridines | 2002 |
Angiotensin-(1-7) and bradykinin interaction in diabetes mellitus: in vivo study.
Topics: Angiotensin I; Animals; Blood Glucose; Bradykinin; Diabetes Mellitus; Enalapril; Insulin; Male; Mesenteric Arteries; Peptide Fragments; Rats; Rats, Wistar | 2002 |
Bradykinin counteracts the stimulatory effect of angiotensin-(1-7) on the proximal tubule Na+ -ATPase activity through B2 receptor.
Topics: Adenosine Triphosphatases; Angiotensin I; Animals; Bradykinin; Bradykinin B2 Receptor Antagonists; Cation Transport Proteins; Kidney Tubules, Proximal; Peptide Fragments; Receptor, Bradykinin B2; Swine | 2003 |
PLA2/PGE2 are involved in the inhibitory effect of bradykinin on the angiotensin-(1-7)-stimulated Na(+)-ATPase activity of the proximal tubule.
Topics: Angiotensin I; Animals; Bradykinin; Bradykinin B2 Receptor Antagonists; Cell Membrane; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Dose-Response Relationship, Drug; Indomethacin; Kidney Tubules, Proximal; Peptide Fragments; Phospholipases A; Phospholipases A2; Quinacrine; Receptor, Bradykinin B2; Sodium-Potassium-Exchanging ATPase; Swine | 2004 |
The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Endothelium-Dependent Relaxing Factors; In Vitro Techniques; Male; Mesenteric Arteries; Mesenteric Veins; Peptide Fragments; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasodilation | 2004 |
Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Aortic Coarctation; Bradykinin; Hypertension; Hypothalamus; Imidazoles; In Vitro Techniques; Nitric Oxide; Norepinephrine; Peptide Fragments; Potassium; Pyridines; Rats; Rats, Wistar | 2004 |
Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Captopril; Drug Synergism; Hypertension; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Peptide Fragments; Rats; Rats, Wistar | 2004 |
Angiotensin-(1-7) and bradykinin in norepinephrine release in the central nervous system of hypertension.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Bradykinin; Hypertension; Hypothalamus; Norepinephrine; Peptide Fragments; Rats; Vasoconstrictor Agents | 2005 |
Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Bradykinin; Enalaprilat; Epoprostenol; Male; Mesentery; Peptide Fragments; Rats; Rats, Inbred SHR | 2005 |
Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors.
Topics: Angiotensin I; Angiotensins; Animals; Bradykinin; CHO Cells; Cricetinae; Cricetulus; Enzyme Inhibitors; Green Fluorescent Proteins; Humans; Hydrolysis; Kinetics; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphoprotein Phosphatases; Protein Kinase C; Protein-Tyrosine Kinases; Receptor, Bradykinin B2; Recombinant Fusion Proteins | 2005 |
Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Carotid Artery, External; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Enalaprilat; Male; Meclofenamic Acid; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents | 2006 |
Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin.
Topics: Angiotensin I; Animals; Animals, Newborn; Blood Glucose; Bradykinin; Diabetes Mellitus, Type 2; Drug Interactions; Gene Expression; Hypoglycemic Agents; Immunohistochemistry; Indomethacin; Insulin; Male; NG-Nitroarginine Methyl Ester; Ouabain; Peptide Fragments; Rats; Rats, Wistar; Receptors, Bradykinin; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin; Tetraethylammonium; Vasodilation | 2007 |
On the mechanism of coronary vasodilation induced by angiotensin-(1-7) in the isolated guinea pig heart.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Bradykinin; Coronary Vessels; Dose-Response Relationship, Drug; Female; Guinea Pigs; Imidazoles; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Pyridines; Vasodilation | 2007 |
Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1-7) nonpeptide mimic AVE 0991 in normotensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Hypotension; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Vasodilator Agents | 2007 |
Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Animals; Bradykinin; Cells, Cultured; Endothelium, Vascular; Humans; In Vitro Techniques; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasodilation | 2007 |
The Bothrops legacy: vasoactive peptides from Brazil.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Atrial Natriuretic Factor; Bradykinin; Calcitonin Gene-Related Peptide; Humans; Oligopeptides; Oxytocin; Peptide Fragments; Peptidyl-Dipeptidase A; Prorenin Receptor; Receptor, Bradykinin B1; Receptors, Angiotensin; Receptors, Cell Surface; Renin-Angiotensin System; rho-Associated Kinases | 2008 |
Effects of intracerebroventricular infusion of angiotensin-(1-7) on bradykinin formation and the kinin receptor expression after focal cerebral ischemia-reperfusion in rats.
Topics: Analysis of Variance; Angiotensin I; Animals; Bradykinin; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Reperfusion; RNA, Messenger | 2008 |
Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Bradykinin; Disease Models, Animal; Heart Ventricles; Hypertension; Male; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphorylation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 2; Up-Regulation | 2010 |
Casein-derived tripeptide Ile-Pro-Pro improves angiotensin-(1-7)- and bradykinin-induced rat mesenteric artery relaxation.
Topics: Angiotensin I; Animals; Blood Pressure; Bradykinin; Captopril; Hypertension; Male; Mesenteric Arteries; Oligopeptides; Peptide Fragments; Rats; Vasodilator Agents | 2011 |
Angiotensin-converting enzyme inhibition, but not AT(1) receptor blockade, in the solitary tract nucleus improves baroreflex sensitivity in anesthetized transgenic hypertensive (mRen2)27 rats.
Topics: Anesthesia; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Baroreflex; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Heart Rate; Hypertension; Male; Microinjections; Oligopeptides; Peptide Fragments; Rats; Rats, Transgenic; Solitary Nucleus; Tetrazoles | 2011 |
Hemodynamic effects of vasorelaxant compounds in mice lacking one, two or all three angiotensin II receptors.
Topics: Acetylcholine; Angiotensin I; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Bradykinin; Heart Rate; Hemodynamics; Male; Mice; Peptide Fragments; Receptors, Angiotensin; Renin-Angiotensin System; Vasodilator Agents | 2012 |
Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Human Umbilical Vein Endothelial Cells; Humans; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Microvessels; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasodilation; Vasodilator Agents | 2013 |
Angiotensin-(1-7) augments endothelium-dependent relaxations of porcine coronary arteries to bradykinin by inhibiting angiotensin-converting enzyme 1.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Vessels; Endothelium; Heart; In Vitro Techniques; Isometric Contraction; Muscle Relaxation; Muscle Tonus; Nitric Oxide; Peptide Fragments; Peptidyl-Dipeptidase A; Swine; Vasodilator Agents | 2014 |
Evidence for an angiotensin-(1-7) neuropeptidase expressed in the brain medulla and CSF of sheep.
Topics: Angiotensin I; Animals; Bradykinin; Chromatography, Agarose; Chromatography, DEAE-Cellulose; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Hydrogen-Ion Concentration; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Kinetics; Medulla Oblongata; Mercury Compounds; Neurotensin; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Protease Inhibitors; Sheep; Substrate Specificity | 2014 |
Modulation of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart failure.
Topics: Angiotensin I; Animals; Bradykinin; Calcium Channels, L-Type; Calcium Signaling; Cardiotonic Agents; Disease Models, Animal; Heart Failure; Isoproterenol; Male; Membrane Potentials; Myocytes, Cardiac; Necrosis; Nitric Oxide; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Time Factors; Ventricular Function, Left | 2015 |
Diabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1-7) and Bradykinin.
Topics: Angiotensin I; Animals; Blood Glucose; Body Weight; Bradykinin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Dosage; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Kidney; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Spectrometry, Fluorescence | 2015 |
Bradykinin -induced vasodilatation: Role of age, ACE1-inhibitory peptide, mas- and bradykinin receptors.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Humans; Hypertension; Mesenteric Arteries; Oligopeptides; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, G-Protein-Coupled; Vasodilation | 2016 |
Angiotensin-(1-7) Selectively Induces Relaxation and Modulates Endothelium-Dependent Dilation in Mesenteric Arteries of Salt-Fed Rats.
Topics: Acetylcholine; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; In Vitro Techniques; Male; Mesenteric Arteries; Nitric Oxide; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Signal Transduction; Sodium Chloride, Dietary; Vasodilation; Vasodilator Agents | 2016 |
The usefulness of angiotensin-(1-7) and des-Arg
Topics: Angiotensin I; Biomarkers; Bradykinin; Humans; Metabolic Syndrome; Peptide Fragments | 2021 |
Scorpion bradykinin potentiating factor mitigates lung damage induced by γ-irradiation in rats: Insights on AngII/ACE/Ang(1-7) axis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Gamma Rays; Lung; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Scorpions | 2021 |